← SynDRA
SALVIANOLIC ACID B
SynDRA canonical compound SYN0019232 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | APP | MMP9 |
|---|
| Mechanism of action | EGFR inhibitor | metalloproteinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- metalloproteinase inhibitor
- IGFBP3 INHIBITOR
Cross-references
Synonyms
- Salvianolic-acid-B
- Lithospermic acid B
- MFCD07779133
- (2R)-2-[(E)-3-[(2R,3R)-3-[(1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyl]oxy-3-(3,4-dihydroxyphenyl)propanoic acid
- (R)-2-(((2R,3R)-4-((E)-3-((R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxoprop-1-en-1-yl)-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydrobenzofuran-3-carbonyl)oxy)-3-(3,4-dihydroxyphenyl)propanoic acid
- Danshensuan B
- Salcianolic acid B
- C36H30O16
- PubChem13035
- CHEMBL3747259
- ZINC49538629
- AKOS015920258
- AS-56980
- S609
- 939S258
- (R)-2-((2R,3R)-4-((E)-3-((R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxoprop-1-enyl)-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydrobenzofuran-3-carbonyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid
- SCHEMBL29350663
- YLSNESYAOIRZEA-AVPWDRFWSA-N
Look up SALVIANOLIC ACID B in the interactive SynDRA portal →